187 related articles for article (PubMed ID: 37989356)
1. Effectiveness of various treatment modalities in children with vesicoureteral reflux grades II-IV: a systematic review and network meta-analysis.
Chang CL; Yang SS; Hsu CK; Chen CH; Chang SJ
BMJ Paediatr Open; 2023 Nov; 7(1):. PubMed ID: 37989356
[TBL] [Abstract][Full Text] [Related]
2. Interventions for primary vesicoureteric reflux.
Williams G; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD001532. PubMed ID: 30784039
[TBL] [Abstract][Full Text] [Related]
3. Interventions for primary vesicoureteric reflux.
Nagler EV; Williams G; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2011 Jun; (6):CD001532. PubMed ID: 21678334
[TBL] [Abstract][Full Text] [Related]
4. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
[TBL] [Abstract][Full Text] [Related]
5. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.
Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S
J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221
[TBL] [Abstract][Full Text] [Related]
6. The Swedish infant high-grade reflux trial: UTI and renal damage.
Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
[TBL] [Abstract][Full Text] [Related]
7. Are prophylactic antibiotics indicated after a urinary tract infection?
Mattoo TK
Curr Opin Pediatr; 2009 Apr; 21(2):203-6. PubMed ID: 19663037
[TBL] [Abstract][Full Text] [Related]
8. Evidence for and against urinary prophylaxis in vesicoureteral reflux.
Mattoo TK
Pediatr Nephrol; 2010 Dec; 25(12):2379-82. PubMed ID: 20725842
[TBL] [Abstract][Full Text] [Related]
9. Do Various Treatment Modalities of Vesicoureteral Reflux Have Any Adverse Effects in Pediatric Patients? A Meta-Analysis.
Xie M; Xu X; Cao Z; Xiao H
Urol Int; 2021; 105(11-12):1002-1010. PubMed ID: 34555831
[TBL] [Abstract][Full Text] [Related]
10. Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.
Ross I; Ahn HJ; Roelof B; Barber T; Huynh V; Rockette A; Popovic M; Chen JJ; Steinhardt G
J Pediatr Urol; 2015 Jun; 11(3):145.e1-6. PubMed ID: 25864614
[TBL] [Abstract][Full Text] [Related]
11. Long-term, low-dose prophylaxis against urinary tract infections in young children.
Brandström P; Hansson S
Pediatr Nephrol; 2015 Mar; 30(3):425-32. PubMed ID: 24906665
[TBL] [Abstract][Full Text] [Related]
12. Renal scarring is the most significant predictor of breakthrough febrile urinary tract infection in patients with simplex and duplex primary vesico-ureteral reflux.
Loukogeorgakis SP; Burnand K; MacDonald A; Wessely K; De Caluwe' D; Rahman N; Farrugia MK
J Pediatr Urol; 2020 Apr; 16(2):189.e1-189.e7. PubMed ID: 31953013
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the management of vesicoureteral reflux: the rationale for the RIVUR study.
Mathews R; Carpenter M; Chesney R; Hoberman A; Keren R; Mattoo T; Moxey-Mims M; Nyberg L; Greenfield S
J Pediatr Urol; 2009 Oct; 5(5):336-41. PubMed ID: 19570724
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Management of Vesicoureteral Reflux.
Hajiyev P; Burgu B
Eur Urol Focus; 2017 Apr; 3(2-3):181-188. PubMed ID: 28918954
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
[TBL] [Abstract][Full Text] [Related]
16. Interventions for primary vesicoureteric reflux.
Hodson EM; Wheeler DM; Vimalchandra D; Smith GH; Craig JC
Cochrane Database Syst Rev; 2007 Jul; (3):CD001532. PubMed ID: 17636679
[TBL] [Abstract][Full Text] [Related]
17. Interventions for primary vesicoureteric reflux.
Wheeler DM; Vimalachandra D; Hodson EM; Roy LP; Smith GH; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD001532. PubMed ID: 15266449
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
19. Primary Vesicoureteral Reflux and Renal Scarring.
Mattoo TK; Mohammad D
Pediatr Clin North Am; 2022 Dec; 69(6):1115-1129. PubMed ID: 36880925
[TBL] [Abstract][Full Text] [Related]
20. [Current status of antibiotic prophylaxis in primary vesicoureteral reflux in children].
Fraga Rodríguez GM; Escribano Subias J; Benito Acin E
Arch Esp Urol; 2008 Mar; 61(2):236-43. PubMed ID: 18491740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
